Changes in Weight, Blood Pressure, and Pulse During the 6-week lead-in period, when all the subjects received sibutramine, there was a mean weight loss of 2.6 kg in the cohort that underwent randomization subsequently. After randomization, there is a further decrease in pounds in the sibutramine group and a mean increase in weight in the placebo group . Thereafter, both organizations had a limited upsurge in mean weight . Comparable mean weight-transformation profiles were seen in analyses of the subjects according to cardiovascular-risk group. There is a mean decrease in blood pressure during the lead-in period .3 to 1 1.2 mm Hg systolic and from 0.6 to 1 1.4 mm Hg diastolic.Think tank that backs a free-market approach to health care, said experts overstated the loss of life risk and didn’t track how long subjects were uninsured . This article is republished with kind permission from our friends at The Kaiser Family Basis. You can view the complete Kaiser Daily Health Policy Survey, search the archives, or sign up for email delivery of in-depth coverage of wellness policy developments, discussions and debates. The Daily Health Plan Report is published for Kaisernetwork.org, a free of charge support of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Organization and Kaiser Family Base. All rights reserved.. AANEM Base strengthens and expands analysis initiatives The AANEM Basis for Research and Education has strengthened and expanded its research initiatives.